Scandinavian CRO (SCRO) is a full-service contract research organization that helps industry and academia develop medicines and medical devices that improve patient health.
For over 15 years, Founder & CEO Ulrika Hammarström has focused on building a sustainable company with a strong company culture and value-based leadership. As a two-time winner of the Gasell from Dagens Industri, SCRO has demonstrated sustainable growth and aims to continue expanding in Scandinavia.
As part of this growth focus, SCRO is proud to announce Ann-Charlotte Beckman as its new Chairman of the Board. Ann-Charlotte has over 30 years of experience in life sciences as an entrepreneur, CEO, board member, advisor, and investor. She is a pioneer in digital health and has worked in both pharma and medtech.
“Ann-Charlotte’s track record is impressive and her deep understanding of the industry will be invaluable in achieving SCRO’s goals,” says Ulrika Hammarström, Founder & CEO at Scandinavian CRO.
” SCRO is a fast-growing company with a solid foundation built on a strong, value-based culture. I’m inspired by the team & look forward to being part of growing the business,” adds Ann-Charlotte Beckman, Chairman of the Board.
To learn about SCRO’s vision for enabling more clinical research & driving better healthcare for patients, visit scro.se
Photo of Ann-Charlotte Beckman, Chairman of the Board, and Ulrika Hammarström, Founder & CEO, Scandinavian CRO
Who is Scandinavian CRO?
Scandinavian CRO (SCRO) is a privately held, full-service Contract Research Organization (CRO) with an office in Gothenburg and headquarters in Uppsala, Sweden. With a team of ca 30 employees and a large network of consultants, SCRO covers Sweden, Norway, Finland and Denmark. SCRO performs complete clinical studies or parts of clinical projects, both for pharmaceuticals and medical devices. With a passion for clinical research and a team with decades of experience, SCRO can provide the expert support you need to succeed in your clinical studies.